-
1
-
-
9144252017
-
Mutations in HFE2 cause iron overload in chromosome 1q-linked juvenile hemochromatosis
-
Papanikolaou, G., et al. 2004. Mutations in HFE2 cause iron overload in chromosome 1q-linked juvenile hemochromatosis. Nat. Genet. 36:77-82.
-
(2004)
Nat. Genet.
, vol.36
, pp. 77-82
-
-
Papanikolaou, G.1
-
2
-
-
23644460325
-
A mouse model of juvenile hemochromatosis
-
doi:10.1172/JCI25049
-
Huang, F.W., Pinkus, J.L., Pinkus, G.S., Fleming, M.D., and Andrews, N.C. 2005. A mouse model of juvenile hemochromatosis. J. Clin. Invest. 115:2187-2191. doi:10.1172/JCI25049.
-
(2005)
J. Clin. Invest.
, vol.115
, pp. 2187-2191
-
-
Huang, F.W.1
Pinkus, J.L.2
Pinkus, G.S.3
Fleming, M.D.4
Andrews, N.C.5
-
3
-
-
23644444316
-
Hemojuvelin is essential for dietary iron sensing, and its mutation leads to severe iron overload
-
doi:10.1172/JCI25683
-
Niederkofler, V., Salie, R., and Arber, S. 2005. Hemojuvelin is essential for dietary iron sensing, and its mutation leads to severe iron overload. J. Clin. Invest. 115:2180-2186. doi:10.1172/JCI25683.
-
(2005)
J. Clin. Invest.
, vol.115
, pp. 2180-2186
-
-
Niederkofler, V.1
Salie, R.2
Arber, S.3
-
5
-
-
2542560427
-
Hereditary hemochromatosis - A new look at an old disease
-
Pietrangelo, A. 2004. Hereditary hemochromatosis-a new look at an old disease. N. Engl. J. Med. 350:2383-2397.
-
(2004)
N. Engl. J. Med.
, vol.350
, pp. 2383-2397
-
-
Pietrangelo, A.1
-
6
-
-
9344224529
-
A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis
-
Feder, J.N., et al. 1996. A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat. Genet. 13:399-408.
-
(1996)
Nat. Genet.
, vol.13
, pp. 399-408
-
-
Feder, J.N.1
-
7
-
-
0034022636
-
The gene TFR2 is mutated in a new type of haemochromatosis mapping to 7q22
-
Camaschella, C., et al. 2000. The gene TFR2 is mutated in a new type of haemochromatosis mapping to 7q22. Nat. Genet. 25:14-15.
-
(2000)
Nat. Genet.
, vol.25
, pp. 14-15
-
-
Camaschella, C.1
-
8
-
-
14544305473
-
New insights into iron homeostasis through the study of non-HFE hereditary haemochromatosis
-
Roetto, A., and Camaschella, C. 2005. New insights into iron homeostasis through the study of non-HFE hereditary haemochromatosis. Best Pract. Res. Clin. Haematol. 18:235-250.
-
(2005)
Best Pract. Res. Clin. Haematol.
, vol.18
, pp. 235-250
-
-
Roetto, A.1
Camaschella, C.2
-
9
-
-
10244265904
-
Diferric transferrin regulates transferrin receptor 2 protein seability
-
Johnson, M.B., and Enns, C.A. 2004. Diferric transferrin regulates transferrin receptor 2 protein seability. Blood. 104:4287-4293.
-
(2004)
Blood
, vol.104
, pp. 4287-4293
-
-
Johnson, M.B.1
Enns, C.A.2
-
10
-
-
10244255021
-
Regulation of transferrin receptor 2 protein levels by transferrin
-
Robb, A., and Wessling-Resnick, M. 2004. Regulation of transferrin receptor 2 protein levels by transferrin. Blood. 104:4294-4299.
-
(2004)
Blood
, vol.104
, pp. 4294-4299
-
-
Robb, A.1
Wessling-Resnick, M.2
-
11
-
-
0001376313
-
HFE gene knockout produces mouse model of hereditary hemochromatosis
-
Zhou, X.Y., et al. 1993. HFE gene knockout produces mouse model of hereditary hemochromatosis. Proc. Natl. Acad. Sci. U. S. A. 95:2492-2497.
-
(1993)
Proc. Natl. Acad. Sci. U. S. A.
, vol.95
, pp. 2492-2497
-
-
Zhou, X.Y.1
-
12
-
-
0033168767
-
The C232Y mutation causing hereditary hemochromatosis does not produce a null slide
-
Levy, J.E., Montross, L.K., Cohen, D.E., Fleming, M.D., and Andrews, N.C. 1999. The C232Y mutation causing hereditary hemochromatosis does not produce a null slide. Blood. 94:9-11.
-
(1999)
Blood
, vol.94
, pp. 9-11
-
-
Levy, J.E.1
Montross, L.K.2
Cohen, D.E.3
Fleming, M.D.4
Andrews, N.C.5
-
13
-
-
0033539556
-
Experimental hemochromatosis due to MHC class I HFE deficiency: Immune status and iron metabolism
-
Bahram, S., et al. 1999. Experimental hemochromatosis due to MHC class I HFE deficiency: immune status and iron metabolism. Proc. Natl. Acad. Sci. U. S. A. 96:13312-13317.
-
(1999)
Proc. Natl. Acad. Sci. U. S. A.
, vol.96
, pp. 13312-13317
-
-
Bahram, S.1
-
14
-
-
0036678091
-
Targeted mutagenesis of the murine transferrin receptor-2 gene produces hemochromatosis
-
Fleming, R.E., et al. 2002. Targeted mutagenesis of the murine transferrin receptor-2 gene produces hemochromatosis. Proc. Natl. Acad. Sci. U. S. A. 99:10653-10658.
-
(2002)
Proc. Natl. Acad. Sci. U. S. A.
, vol.99
, pp. 10653-10658
-
-
Fleming, R.E.1
-
15
-
-
14544298717
-
Hepcidin - A regulator of intestinal iron absorption and iron recycling by macrophages
-
Ganz, T. 2005. Hepcidin-a regulator of intestinal iron absorption and iron recycling by macrophages. Best Pract. Res. Clin. Haematol. 18:171-182.
-
(2005)
Best Pract. Res. Clin. Haematol.
, vol.18
, pp. 171-182
-
-
Ganz, T.1
-
16
-
-
0035902605
-
Lack of hepcidin gene expression and severe tissue iron overload in upstream stimulatory factor 2 (USF2) knockout mice
-
Nicolas, G., et al. 2001. Lack of hepcidin gene expression and severe tissue iron overload in upstream stimulatory factor 2 (USF2) knockout mice. Proc. Natl. Acad. Sci. U. S. A. 98:8780-8785.
-
(2001)
Proc. Natl. Acad. Sci. U. S. A.
, vol.98
, pp. 8780-8785
-
-
Nicolas, G.1
-
17
-
-
0037007064
-
Severe iron deficiency anemia in transgenic mice expressing liver hepcidin
-
Nicolas, G., et al. 2002. Severe iron deficiency anemia in transgenic mice expressing liver hepcidin. Proc. Natl. Acad. Sci. U. S. A. 99:4596-4601.
-
(2002)
Proc. Natl. Acad. Sci. U. S. A.
, vol.99
, pp. 4596-4601
-
-
Nicolas, G.1
-
18
-
-
10844258104
-
Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization
-
Nemeth, E., et al. 2004. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science. 306:2090-2093.
-
(2004)
Science
, vol.306
, pp. 2090-2093
-
-
Nemeth, E.1
-
19
-
-
13444252281
-
Iron release from macrophages after erythrophagocytosis is up-regulated by ferroportin 1 overexpression and down-regulated by hepcidin
-
Knutson, M.D., Oukka, M., Koss, L.M., Aydemir, F., and Wessling-Resnick, M. 2005. Iron release from macrophages after erythrophagocytosis is up-regulated by ferroportin 1 overexpression and down-regulated by hepcidin. Proc. Natl. Acad. Sci. U. S. A. 102:1324-1328.
-
(2005)
Proc. Natl. Acad. Sci. U. S. A.
, vol.102
, pp. 1324-1328
-
-
Knutson, M.D.1
Oukka, M.2
Koss, L.M.3
Aydemir, F.4
Wessling-Resnick, M.5
-
20
-
-
20444416123
-
The iron exporter ferroportin (Slc40a1) is essential for iron homeostasis
-
Donovan, A., et al. 2005. The iron exporter ferroportin (Slc40a1) is essential for iron homeostasis. Cell Metabolism. 1:191-200.
-
(2005)
Cell Metabolism
, vol.1
, pp. 191-200
-
-
Donovan, A.1
-
21
-
-
0038312385
-
Decreased liver hepcidin expression in the hfe knockout mouse
-
Ahmad, K.A., et al. 2002. Decreased liver hepcidin expression in the hfe knockout mouse. Blood Cells Mol. Dis. 29:361-366.
-
(2002)
Blood Cells Mol. Dis.
, vol.29
, pp. 361-366
-
-
Ahmad, K.A.1
-
22
-
-
0037460697
-
Disrupted hepcidin regulation in HFE-associated haemochromatosis and the liver as a regulator of body iron homeostasis
-
Bridle, K.R., et al. 2003. Disrupted hepcidin regulation in HFE-associated haemochromatosis and the liver as a regulator of body iron homeostasis. Lancet. 361:669-673.
-
(2003)
Lancet
, vol.361
, pp. 669-673
-
-
Bridle, K.R.1
-
23
-
-
0038662619
-
Hepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein
-
Nemeth, E., et al. 2003. Hepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein. Blood. 101:2461-2463.
-
(2003)
Blood
, vol.101
, pp. 2461-2463
-
-
Nemeth, E.1
-
24
-
-
0037847496
-
Constitutive hepcidin expression prevents iron overload in a mouse model of hemochromatosis
-
Nicolas, G., et al. 2003. Constitutive hepcidin expression prevents iron overload in a mouse model of hemochromatosis. Nat. Genet. 34:97-101.
-
(2003)
Nat. Genet.
, vol.34
, pp. 97-101
-
-
Nicolas, G.1
-
25
-
-
0037509928
-
Regulatory defects in liver and intestine implicate abnormal hepcidin and Cybrd1 expression in mouse hemochromatosis
-
Muckenthaler, M., et al. 2003. Regulatory defects in liver and intestine implicate abnormal hepcidin and Cybrd1 expression in mouse hemochromatosis. Nat. Genet. 34:102-107.
-
(2003)
Nat. Genet.
, vol.34
, pp. 102-107
-
-
Muckenthaler, M.1
-
26
-
-
19944427107
-
Expression of hepcidin is down-regulated in TfR2 mutant mice manifesting a phenotype of hereditary hemochromatosis
-
Kawabata, H., et al. 2005. Expression of hepcidin is down-regulated in TfR2 mutant mice manifesting a phenotype of hereditary hemochromatosis. Blood. 105:376-381.
-
(2005)
Blood
, vol.105
, pp. 376-381
-
-
Kawabata, H.1
-
27
-
-
14644400943
-
Hepcidin is decreased in TFR2-hemochromatosis
-
Nemeth, E., Roetto, A., Garozzo, G., Ganz, T., and Camaschella, C. 2004. Hepcidin is decreased in TFR2-hemochromatosis. Blood. 105:4103-4105.
-
(2004)
Blood
, vol.105
, pp. 4103-4105
-
-
Nemeth, E.1
Roetto, A.2
Garozzo, G.3
Ganz, T.4
Camaschella, C.5
-
29
-
-
19544386871
-
Hepcidin in iron overload disorders
-
Papanikolaou, G., et al. 2005. Hepcidin in iron overload disorders. Blood. 105:4103-4105.
-
(2005)
Blood
, vol.105
, pp. 4103-4105
-
-
Papanikolaou, G.1
-
30
-
-
20444413054
-
Deregulation of proteins involved in iron metabolism in hepcidin-deficient mice
-
Viatce, L., et al. 2005. Deregulation of proteins involved in iron metabolism in hepcidin-deficient mice. Blood. 105:4861-4864.
-
(2005)
Blood
, vol.105
, pp. 4861-4864
-
-
Viatce, L.1
-
31
-
-
23044508432
-
Resistance to hepcidin is conferred by hemochromatosis-associated mutations of ferroportin
-
doi:10.1182/blood-2005-02-0561
-
Drakesmith, H., et al. 2005. Resistance to hepcidin is conferred by hemochromatosis-associated mutations of ferroportin. Blood. doi:10.1182/blood- 2005-02-0561.
-
(2005)
Blood
-
-
Drakesmith, H.1
-
32
-
-
0036791486
-
The gene encoding the iron regulatory peptide hepcidin is regulated by anemia, hypoxia, and inflammation
-
doi:10.1172/JCI200215686
-
Nicolas, G., et al. 2002. The gene encoding the iron regulatory peptide hepcidin is regulated by anemia, hypoxia, and inflammation. J. Clin. Invest. 110:1037-1044. doi:10.1172/JCI200215686.
-
(2002)
J. Clin. Invest.
, vol.110
, pp. 1037-1044
-
-
Nicolas, G.1
|